Rarebase

Business Services · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Rarebase

Transcripta Bio, Inc. specializes in transcriptome-driven drug discovery using AI to analyze how various drugs influence gene activity. Their platform screens thousands of molecules across 20,000 genes, creating a detailed map that connects chemical structures to gene expression. By synthesizing and measuring billions of novel compounds, they predict gene responses and unlock therapeutic hypotheses. The company aims to transform insights into innovative therapies, addressing opportunities across all human diseases.Explore more
Rarebase's Social MediaPopular SearchesRarebaseRarebase , PBCRarebase.comSIC Code 87,873NAICS Code 54,541Show more

Rarebase Org Chart

PhoneEmail
Clayton Mellina, Chief Technology Officer at Rarebase
United States flag for contact location.

Chief Technology Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
MB
United States flag for contact location.

Scientific Drug Development Advisor

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Rarebase your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Rarebase

Compare insights from companies similar to Rarebase, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Rarebase

<$5M
1-10
Private
-
2020
Clayton Mellina, Chief Technology Officer at Rarebase
Clayton MellinaChief Technology Officer
$9.1M
11-50
Private
$40.5M
2019
Ho-Juhn Song, Co-Founder & Chief Executive Officer at PineTree Therapeutics
Ho-Juhn SongCo-Founder & CEO
<$5M
11-50
Private
$37M
2015
<$5M
11-50
Private
-
2020
N/A
<$5M
1-10
Private
<$5M
2020
N/A
<$5M
11-50
Private
-
2016
CC
Cintia CordovaVice President, Manufacturing Operations
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Rarebase is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Rarebase is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Rarebase.

Rarebase Tech Stack

Most Recent Scoops

Event
Person-Based
Christopher Moxham, Chief Executive Officer, appeared on a podcast called "The Kara Goldin Show" on 04/16/2025. Topics discussed include Biotech, AI, drug discovery, transcriptomics, leadership..
Events, Podcast
Lateral Move
Executive Move
Promotion
Executive Move
Promotion
Executive Move
See more scoops

Rarebase News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Rarebase

What is Rarebase's official website?
Rarebase's official website is www.rarebase.org
What is Rarebase's Revenue?
Rarebase's revenue is <$5 Million
What is Rarebase's SIC code?
Rarebase's SIC: 87,873
What is Rarebase's NAICS code?
Rarebase's NAICS: 54,541
How many employees does Rarebase have?
Rarebase has 1-10 employees
What industry does Rarebase belong to?
Rarebase is in the industry of: Business Services, Research & Development
What is Rarebase competition?
Rarebase top competitors include: Cost Plus Drugs, Syngle Therapeutics, Bilayer Therapeutics, Ophirex
What technology does Rarebase use?
Some of the popular technologies that Rarebase uses are: Google Cloud DNS, Cloudflare CDN, Google Cloud Platform, Apache Hadoop
Who is the CTO of Rarebase?
Rarebase's CTO is Clayton Mellina
What does Rarebase do?

Transcripta Bio, Inc. specializes in transcriptome-driven drug discovery using AI to analyze how various drugs influence gene activity. Their platform screens thousands of molecules across 20,000 genes, creating a detailed map that connects chemical structures to gene expression. By synthesizing and measuring billions of novel compounds, they predi... ct gene responses and unlock therapeutic hypotheses. The company aims to transform insights into innovative therapies, addressing opportunities across all human diseases.Read More

What are Rarebase social media links?
Rarebase Linkedin page Rarebase Twitter page
Is Rarebase a public company?
Rarebase is private company therefore does not currently have an official ticker symbol
See more information about Rarebase

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.